In 2010, the American Medical Association (AMA) published a series of reports entitled “AMA Scope of Practice Data Series.”  One report focused on the pharmacy profession, which criticized the formation of CPAs as an attempt by pharmacists to intervene with the physician. In response to the report, a collaboration of seven national pharmacists` associations prepared a response to the WADA Pharmacists Report.  The response called on WADA to correct its report and publish the revised report with Errata.  In 2011, the WADA Chamber of Deputies adopted a more flexible tone of the APhA in response to contributions from aPhA and other pharmacy professional associations and finally adopted the following resolution: which focused the Attention to the rejection of independent (rather than collaborative or dependent) practice agreements: CDTM is an extension of the traditional pharmacist practice that allows pharmacists to manage drug-related problems (DPDs) based on a collaborative and interdisciplinary approach to pharmaceutical practice. The conditions of a CPA are defined by the pharmacist and the cooperating physician, although models exist online. CPAs may be specific to a patient population of interest to both parties, a specific clinical situation or disease, and/or a factual protocol for managing the drug treatment of patients under CPA. CPAs have been the subject of intensive debate in pharmacy and medicine. Thanks for the presentation of the article very well rounded. The only thing missing is the definition of MD surveillance, which is never clearly expressed. A collaborative NP/MD agreement indicates that the NP MD will be available for consultation. Period.
This means that nurse practitioners already see patients independently. The NP decides whether a second opinion is needed at this time. The decision to take over the DM board is also optional. How does this regulation lead to safer, better quality or more comprehensive patient care? And the MD has the right to have an unlimited number of NPs? What are the concerns about patient safety? It is clearly a matter of generating unlimited revenue for the cooperating MD. And drive the NPs out of the state. For more information on collaborative divorce, see: www.collaborativedivorcecalifornia.com. D`Arkansan CPs apply to individual pharmacists, practitioners who are “authorized to prescribe drugs” and who are indicated in patients. The specific disease stipulates that pharmacists administer, with indicated medications that the pharmacist can use are necessary.